Cortechs.ai | Poster – Performance Evaluation for Automated Lesion Segmentation Tool: LesionQuant

Poster – Performance Evaluation for Automated Lesion Segmentation Tool: LesionQuant

Cortechs.ai was pleased to present this poster at AAN in Boston – April 2017.

Quantitative measures such as lesion volume and distribution have significant value for clinicians evaluating disease progression. Clinical standards for lesion evaluation include visual inspection of MRI images, or expert manual segmentation of lesions. These subjective measurements are often vulnerable to inter- and intra-rater variability, resulting in low reproducibility.

Cortechs.ai’ LesionQuant is a fully-automated lesion segmentation tool for clinical use designed to provide accurate and reproducible lesion segmentations. This study objectively demonstrates that the accuracy of LesionQuant is comparable to expert manual segmentation of lesions and had high reproducibility, making it a useful tool in the quantitative analysis of the brain lesions.

For more information about LesionQuant or this poster, contact us. Click image below to view in pdf.

Cortechs.ai | Poster – Performance Evaluation for Automated Lesion Segmentation Tool: LesionQuant

More Resources

06/04/2026

SNMMI 2026: Advancing the Future of Quantitative PET in Dementia Imaging

At SNMMI 2026, Cortechs.ai showcased NeuroQuant® PET and the growing role of quantitative PET imaging in dementia care.

06/02/2026

Cortechs.ai Collaborates with Microsoft to Bring AI-Powered Imaging Insights Directly into Radiology Workflows

Cortechs.ai and Microsoft are partnering to help bring advanced AI-powered quantitative imaging directly into radiology workflows.

05/26/2026

Cortechs.ai Partners with ARJ Medical to Advance AI-Driven Neuro and Prostate Imaging in the Middle East

Cortechs.ai and ARJ Medical have partnered to expand access to AI-powered neuro and prostate imaging solutions across the Middle East.

05/26/2026

ASNR 2026 Highlights the Growing Role of Quantitative Imaging in Neurology

ASNR 2026 brought together leaders across neuroradiology, imaging AI, and neurological care to explore the future of quantitative imaging.

05/11/2026

Better Models, Better Care: Inside Our Latest Brain Tumor Update

Explore how NeuroQuant® Brain Tumor v2.1 advances AI-powered brain tumor segmentation and clinical workflows.

05/05/2026

The American Academy of Neurology: Shaping the Future of Neurologic Care 

AI-driven clinical quantification is becoming standard in neurologic care
Scroll to Top